SCHEMBL1865107

SCHEMBL1865107

O=C(O)N1CCC(NS(=O)(=O)c2ccc([N+](=O)[O-])cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
POLB P06746 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
CA2 P00918 5/20 0.48
CA1 P00915 4/20 0.48
MMP1 P03956 1/20 0.48
MMP2 P08253 1/20 0.48
MMP9 P14780 1/20 0.48
MMP8 P22894 1/20 0.48
MMP13 P45452 1/20 0.48
CA9 Q16790 4/20 0.47
KDM4E B2RXH2 1/20 0.46
RECQL P46063 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ALDH1A1 P00352 1/20 0.45
EPHX2 P34913 2/20 0.45
CA12 O43570 3/20 0.44
CA7 P43166 2/20 0.44
CA14 Q9ULX7 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4123220 0.92 CA1 (0.48) MEN1KMT2APOLBTDP1CA2
SCHEMBL29222155 0.92 CA1 (0.48) MEN1KMT2APOLBTDP1CA2
SCHEMBL6418180 0.84 MEN1 (0.49) MEN1KMT2APOLBTDP1SMN1; SMN2
SCHEMBL6418177 0.84 MEN1 (0.49) MEN1KMT2APOLBTDP1SMN1; SMN2
SCHEMBL28045965 0.83 KDM4E (0.61) MEN1KMT2APOLBTDP1CA2
SCHEMBL27900148 0.82 MEN1 (0.53) MEN1KMT2AKDM4ERECQLSMN1; SMN2
SCHEMBL4966206 0.82 ALDH1A1 (0.66) MEN1KMT2APOLBKDM4ERECQL
SCHEMBL27917822 0.82 HTT (0.62) MEN1KMT2AKDM4ERECQLSMN1; SMN2
Bicarbonate SCHEMBL15226074 0.82 SMN1; SMN2 (0.63) MEN1KMT2AKDM4ERECQLSMN1; SMN2
SCHEMBL3668793 0.82 CA1 (0.51) MEN1KMT2APOLBTDP1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011060321-A1 TRANSGLUTAMINASE TG2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF CHDI, INC. (US) 2011-05-19 WO disclosed